Analysts Set UiPath, Inc. (NYSE:PATH) Target Price at $13.83

UiPath, Inc. (NYSE:PATH) has been given an average recommendation of “Hold” by the sixteen research firms that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, twelve have issued a hold recommendation and two have issued a buy recommendation on the company. The average 12-month target price among brokers that have covered the stock in the last year is $13.83.

A number of equities research analysts recently issued reports on PATH shares. Royal Bank Of Canada raised their price target on UiPath from $13.00 to $15.00 and gave the stock a “sector perform” rating in a research note on Friday, May 30th. Truist Financial boosted their price objective on shares of UiPath from $12.00 to $13.00 and gave the company a “hold” rating in a research report on Friday, May 30th. Wells Fargo & Company reaffirmed an “equal weight” rating on shares of UiPath in a research report on Friday, May 30th. UBS Group decreased their price target on shares of UiPath from $14.00 to $10.00 and set a “sell” rating for the company in a research note on Thursday, March 13th. Finally, BMO Capital Markets increased their price objective on UiPath from $11.50 to $15.50 and gave the stock a “market perform” rating in a research note on Friday, May 30th.

UiPath Stock Performance

NYSE PATH opened at $13.27 on Thursday. The business’s 50 day moving average price is $12.60 and its 200-day moving average price is $12.47. UiPath has a fifty-two week low of $9.38 and a fifty-two week high of $15.93. The company has a market cap of $7.10 billion, a P/E ratio of -110.57, a P/E/G ratio of 17.41 and a beta of 1.04.

UiPath (NYSE:PATH) last released its earnings results on Thursday, May 29th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The firm had revenue of $356.62 million during the quarter, compared to analyst estimates of $332.17 million. During the same quarter last year, the business earned $0.13 EPS. The business’s revenue was up 6.4% on a year-over-year basis. As a group, equities analysts predict that UiPath will post -0.17 EPS for the current year.

Insider Activity

In other UiPath news, CEO Daniel Dines sold 45,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $12.54, for a total value of $564,300.00. Following the completion of the sale, the chief executive officer directly owned 5,463,376 shares in the company, valued at $68,510,735.04. This trade represents a 0.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Ashim Gupta sold 98,795 shares of the company’s stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $12.01, for a total value of $1,186,527.95. Following the transaction, the chief financial officer directly owned 987,322 shares in the company, valued at approximately $11,857,737.22. The trade was a 9.10% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 380,117 shares of company stock worth $4,726,694 in the last quarter. 23.19% of the stock is owned by insiders.

Institutional Trading of UiPath

Institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its stake in UiPath by 3.0% in the first quarter. Vanguard Group Inc. now owns 48,061,096 shares of the company’s stock valued at $495,029,000 after buying an additional 1,396,972 shares during the last quarter. Senvest Management LLC boosted its stake in UiPath by 29.2% in the 4th quarter. Senvest Management LLC now owns 14,074,783 shares of the company’s stock worth $178,890,000 after purchasing an additional 3,180,300 shares in the last quarter. AQR Capital Management LLC boosted its stake in UiPath by 45.3% in the 4th quarter. AQR Capital Management LLC now owns 6,646,320 shares of the company’s stock worth $84,209,000 after purchasing an additional 2,072,089 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of UiPath by 10.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,132,003 shares of the company’s stock worth $63,164,000 after buying an additional 602,866 shares during the last quarter. Finally, Federated Hermes Inc. lifted its stake in shares of UiPath by 479.3% during the first quarter. Federated Hermes Inc. now owns 5,720,096 shares of the company’s stock worth $58,917,000 after buying an additional 4,732,712 shares during the period. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.